Company profile: Genetic
1.1 - Company Overview
Company description
- Provider of integrated pharmaceutical research, development, manufacturing and licensing of pharmaceutical specialties and medical devices, focused on respiratory and ophthalmology. Offers proprietary medicines (nebulization and oral liquids, tablets, capsules), ophthalmic and respiratory products (pMDI, nebulizers), preservative-free eye drops and nasal sprays, out-licensing/third-party production, and pharmacovigilance.
Products and services
- Respiratory Products: Engineers drugs for asthma, COPD, and other respiratory conditions, delivered via Metered Dose inhalers (pMDI) and nebulizer liquids using Blow-Fill-Seal technology, enabling single-dose delivery (unit-dose)
- Ophthalmic Products: Produces ophthalmic antihypertensives, antibiotics, corticosteroids, and anti-inflammatory drugs in various formulations, leveraging Blow-Fill-Seal unit-dose formats for single-dose administration (unit-dose)
- Medical Devices: Fabricates eye drops and nasal sprays, offering preservative-free formulations and variants with added hyaluronic acid for ocular and nasal applications (preservative-free)
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Genetic
Jubilee Clinical Research
HQ: United States
Website
- Description: Provider of clinical research across diverse indications, including new antibiotic developments and the latest diabetic therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jubilee Clinical Research company profile →
CordenPharma
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing services to pharmaceutical and biotechnology companies, including APIs with development, scale-up and regulatory support; non-sterile and sterile drug products (oral solids, liquids, lyophilized); synthetic lipid excipients (standard and custom); peptide development and manufacturing; and support for bioavailability, LNP formulation/manufacturing, and packaging.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CordenPharma company profile →
PharmaCell
HQ: The Netherlands
Website
- Description: Provider of GMP-certified cell-culturing and contract manufacturing services for cellular therapies and regenerative medicine in Europe, operating facilities in Maastricht and Geleen. Serves world-leading commercial cell therapy companies and offers support or partnership to R&D companies through an extensive network.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaCell company profile →
OcellO
HQ: The Netherlands
Website
- Description: Provider of CRO services for the drug discovery industry, developing clinically relevant in vitro human micro-tissue models for screening and profiling of small molecules and biologics to improve the efficiency of lead development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OcellO company profile →
Quotient Sciences
HQ: United Kingdom
Website
- Description: Provider of formulation development, clinical pharmacology, and clinical-to-commercial manufacturing. Services span preformulation; small-batch supply to accelerate POC; 14-day make-test cycles in humans; process development and scale-up through Phase II/III; commercial manufacturing for ANDA/NDA/MAA/Japanese NDA; and Translational Pharmaceutics integrating formulation, adaptive GMP manufacturing, and clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quotient Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Genetic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Genetic
2.2 - Growth funds investing in similar companies to Genetic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Genetic
4.2 - Public trading comparable groups for Genetic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →